Elizabeth Kornaga

719 total citations
24 papers, 437 citations indexed

About

Elizabeth Kornaga is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Elizabeth Kornaga has authored 24 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Elizabeth Kornaga's work include Breast Cancer Treatment Studies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (4 papers). Elizabeth Kornaga is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (4 papers). Elizabeth Kornaga collaborates with scholars based in Canada, United States and United Kingdom. Elizabeth Kornaga's co-authors include Anthony M. Magliocco, Susan P. Lees‐Miller, Emeka K. Enwere, Corinne Doll, Prafull Ghatage, Tien Phan, Michelle L. Dean, Martin Köbel, Alexander C. Klimowicz and Pinaki Bose and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Elizabeth Kornaga

23 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Kornaga Canada	11	255	152	95	88	82	24	437
Ana T. Nunes United States	11	275 1.1×	120 0.8×	78 0.8×	52 0.6×	39 0.5×	19	455
Phil Rolland United Kingdom	10	229 0.9×	190 1.3×	137 1.4×	88 1.0×	51 0.6×	11	582
Seyran Yiğit Türkiye	14	181 0.7×	76 0.5×	55 0.6×	93 1.1×	74 0.9×	43	433
E Patsouris Greece	13	156 0.6×	166 1.1×	29 0.3×	89 1.0×	64 0.8×	31	393
Renato José Affonso Brazil	7	106 0.4×	81 0.5×	81 0.9×	83 0.9×	70 0.9×	9	288
Shengwei Mo China	11	217 0.9×	93 0.6×	36 0.4×	56 0.6×	30 0.4×	30	348
Masataka Takenaka Japan	9	96 0.4×	133 0.9×	43 0.5×	54 0.6×	67 0.8×	22	342
Marina Asher United States	8	139 0.5×	212 1.4×	199 2.1×	144 1.6×	39 0.5×	10	560
A. Biete Spain	9	147 0.6×	112 0.7×	33 0.3×	93 1.1×	110 1.3×	25	425

Countries citing papers authored by Elizabeth Kornaga

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Kornaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Kornaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Kornaga more than expected).

Fields of papers citing papers by Elizabeth Kornaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Kornaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Kornaga. The network helps show where Elizabeth Kornaga may publish in the future.

Co-authorship network of co-authors of Elizabeth Kornaga

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Kornaga. A scholar is included among the top collaborators of Elizabeth Kornaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Kornaga. Elizabeth Kornaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martell, Kevin, John B. McIntyre, Tasnima Abedin, et al.. (2023). Prevalence and Prognostic Significance of PIK3CA Mutation and CNV Status and Phosphorylated AKT Expression in Patients With Cervical Cancer Treated With Primary Surgery. International Journal of Gynecological Pathology. 43(2). 158–170. 1 indexed citations

Chan, Angela, Gloria Roldan Urgoiti, Elizabeth Kornaga, et al.. (2022). The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy. Frontiers in Oncology. 12. 1000263–1000263. 5 indexed citations

Ye, Xianjun, Maja H. Oktay, Xiaonan Xue, et al.. (2022). Combining TMEM Doorway Score and MenaCalc Score Improves the Prediction of Distant Recurrence Risk in HR+/HER2− Breast Cancer Patients. Cancers. 14(9). 2168–2168. 2 indexed citations

Bartlett, John M.S., Jane Bayani, Elizabeth Kornaga, et al.. (2021). Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study. npj Breast Cancer. 7(1). 90–90. 5 indexed citations

Bartlett, John M.S., Jane Bayani, Elizabeth Kornaga, et al.. (2020). Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training. PLoS ONE. 15(9). e0238593–e0238593. 6 indexed citations

Martell, Kevin, John B. McIntyre, Elizabeth Kornaga, et al.. (2020). PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer. Gynecologic Oncology. 158(3). 776–784. 16 indexed citations

Pereira, Allan Andresson Lima, et al.. (2018). Comparison of clinical characteristics and survival of metastatic breast cancer patients in United States according to insurance status as compared to outcomes in Canada.. Journal of Clinical Oncology. 36(15_suppl). e18617–e18617. 1 indexed citations

Urgoiti, Gloria Roldan, Elizabeth Kornaga, Raymond S. Yeung, et al.. (2018). The Prognostic Impact of PD-L1 and CD8 Expression in Anal Cancer Patients Treated with Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics. 102(3). S62–S63.

Enwere, Emeka K., Elizabeth Kornaga, Michelle L. Dean, et al.. (2017). Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer. Modern Pathology. 30(4). 577–586. 145 indexed citations

10.

Bayani, Jane, Elizabeth Kornaga, Gun Ho Jang, et al.. (2017). Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers.. Journal of Clinical Oncology. 35(15_suppl). 524–524. 1 indexed citations

11.

Kornaga, Elizabeth, Robyn Banerjee, Tien Phan, et al.. (2017). Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study. Clinical and Translational Radiation Oncology. 4. 51–56. 41 indexed citations

12.

Ho, Clement, Elizabeth Kornaga, Alexander C. Klimowicz, et al.. (2017). Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy. Gynecologic Oncology. 145(1). 176–184. 13 indexed citations

13.

Chanda, Ayan, Angela Chan, Lili Deng, et al.. (2017). Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer. PLoS ONE. 12(5). e0177639–e0177639. 34 indexed citations

14.

Doll, Corinne, Jennifer Moughan, Alexander C. Klimowicz, et al.. (2016). Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811. International Journal of Radiation Oncology*Biology*Physics. 97(3). 554–562. 9 indexed citations

15.

Kornaga, Elizabeth, Alexander C. Klimowicz, Travis Ogilvie, et al.. (2016). A systematic comparison of three commercial estrogen receptor assays in a single clinical outcome breast cancer cohort. Modern Pathology. 29(8). 799–809. 19 indexed citations

16.

Kornaga, Elizabeth, Alexander C. Klimowicz, Travis Ogilvie, et al.. (2016). Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort. Modern Pathology. 29(12). 1492–1500. 9 indexed citations

17.

Feng, Xiaolan, Haocheng Li, Elizabeth Kornaga, et al.. (2016). Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancer. Oncotarget. 7(52). 85798–85812. 10 indexed citations

18.

Feng, Xiaolan, Haocheng Li, Michelle L. Dean, et al.. (2015). Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer. Breast Cancer Research. 17(1). 65–65. 32 indexed citations

19.

Bose, Pinaki, Nigel T. Brockton, Steven C. Nakoneshny, et al.. (2015). Fractal analysis of nuclear histology integrates tumor and stromal features into a single prognostic factor of the oral cancer microenvironment. BMC Cancer. 15(1). 409–409. 18 indexed citations

20.

Bose, Pinaki, Alexander C. Klimowicz, Elizabeth Kornaga, et al.. (2012). Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma. BMC Cancer. 12(1). 332–332. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact